2009
DOI: 10.1159/000325381
|View full text |Cite
|
Sign up to set email alerts
|

Galectin-3 Cytotest in Thyroid Follicular Neoplasia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
13
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 17 publications
(14 citation statements)
references
References 24 publications
1
13
0
Order By: Relevance
“…In this study, all papillary carcinoma cases showed diffuse expression of Galectin-3, the finding which was also highlighted by Haugen et al [38] and Pennelli et al [51], and was explained by Yoshii et al [55] as the expression of Galectin-3 appears to be necessary for the maintenance of transformed thyroid papillary cancer cell line in vitro. Papotti et al [56] agreed also with this finding and put great emphasis on the role of Galectin-3 in differentiating between cystic papillary carcinoma and benign thyroid cysts.…”
Section: Galectin-3 X 400) 2-b: Follicular Carcinoma Showing Diffusesupporting
confidence: 84%
See 2 more Smart Citations
“…In this study, all papillary carcinoma cases showed diffuse expression of Galectin-3, the finding which was also highlighted by Haugen et al [38] and Pennelli et al [51], and was explained by Yoshii et al [55] as the expression of Galectin-3 appears to be necessary for the maintenance of transformed thyroid papillary cancer cell line in vitro. Papotti et al [56] agreed also with this finding and put great emphasis on the role of Galectin-3 in differentiating between cystic papillary carcinoma and benign thyroid cysts.…”
Section: Galectin-3 X 400) 2-b: Follicular Carcinoma Showing Diffusesupporting
confidence: 84%
“…Pennelli et al [51] and Chiu et al [52] agreed that Galectin-3 over-expression (moderate and diffuse scoring) was a good predictor for thyroid cancer and an unequivocal indication for surgery. Nearly similar values of sensitivity, specificity and accuracy were also reached by Saggiorato et al [14], Bartolazzi et al [15] and Aiad et al [53], all suggested that the routine correct use of galectin3can increase the diagnostic accuracy of conventional cytology especially in the indeterminate group, hence improve the management of thyroid nodules and reduce unnecessary thyroid surgeries.…”
Section: Galectin-3 X 400) 2-b: Follicular Carcinoma Showing Diffusementioning
confidence: 97%
See 1 more Smart Citation
“…Bartolazzi et al (46) examined Gal-3 expression in 1009 thyroid lesion samples and 226 FNAB cytological results, which showed 98% sensitivity and 99% specificity to discriminate benign and malignant lesions. Pennelli et al (85) corroborated these results by observing an 80% sensitivity and an 86% specificity in a group of one hundred indeterminate cytological nodules.…”
Section: Tumor Markers Of Thyroid Cytology (Fnab): Indications and CLmentioning
confidence: 73%
“…The appropriate indication of molecular immunocytochemical markers of malignancy increased with the diagnostic pitfalls of Bethesda categories III, IV, and V (20,24,25,84,85). …”
Section: Tumor Markers Of Thyroid Cytology (Fnab): Indications and CLmentioning
confidence: 99%